RIPE Knowledge Graph
RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1136%2Fbmj-2025-084418

https://w3id.org/ripe/ripe-kg/work/10.1136%2Fbmj-2025-084418
SubjectPredicateObject
ripekg:publication-details/RIPEA61C486302F135B42Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial ripe:concerns ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial
ripekg:publication-details/RIPEA61C486302F135B42Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial ripe:concerns ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj
ripekg:registry-evidence/RIPEA61C486302F135B42 ripe:concerns ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial
ripekg:registry-evidence/RIPEA61C486302F135B42 ripe:concerns ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj
ripekg:research-integrity-assessment/RIPEA61C486302F135B42 ripe:assesses ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial
ripekg:research-integrity-assessment/RIPEA61C486302F135B42 ripe:assesses ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj
ripekg:study-design-evidence/RIPEA61C486302F135B42 ripe:concerns ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial
ripekg:study-design-evidence/RIPEA61C486302F135B42 ripe:concerns ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial prism:doi 10.1136/bmj-2025-084418
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj prism:doi 10.1136/bmj-2025-084418
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU0E057E6557198676Ping Wang
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU0E057E6557198676Ping Wang
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU0F3F91252CFA318CHongbin Xie
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU0F3F91252CFA318CHongbin Xie
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU116286EA408FA680Shuo Liang
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU116286EA408FA680Shuo Liang
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU147BD6E28AC70AA5Qiao Weng
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU147BD6E28AC70AA5Qiao Weng
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU17CB02671DDF8806Ying Zhou
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU17CB02671DDF8806Ying Zhou
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU1865F3CC7FE055CEZheng Fang
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU1865F3CC7FE055CEZheng Fang
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU20BE31A53BF1585DLan Zhu
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU20BE31A53BF1585DLan Zhu
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU2B5EE40BCC31CBDAXuemei Wang
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU2B5EE40BCC31CBDAXuemei Wang
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU2B98FE7A137FC08DAbraham Morse
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU2B98FE7A137FC08DAbraham Morse
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU4425EDEECE160500Fengbin Jin
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU4425EDEECE160500Fengbin Jin
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU65956103CD04B92DKai Zhou
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU65956103CD04B92DKai Zhou
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU683C7296D83B3BC2Xiangjuan Li
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU683C7296D83B3BC2Xiangjuan Li
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU8059004FA92D7BA0Nannan Liang
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU8059004FA92D7BA0Nannan Liang
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU832261B67D8B44D4Yuelun Zhang
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU832261B67D8B44D4Yuelun Zhang
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAU8D3E45618E3BC501Yinghui He
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAU8D3E45618E3BC501Yinghui He
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAUA80B7C89D6A4C2D8Haiyan Shen
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAUA80B7C89D6A4C2D8Haiyan Shen
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAUC0BC445776836E4ABengui Jiang
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAUC0BC445776836E4ABengui Jiang
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAUD9B817A74F1A3F85Yingying Dai
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAUD9B817A74F1A3F85Yingying Dai
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAUDD2302CA02013E0DCheng Peng
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAUDD2302CA02013E0DCheng Peng
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAUEAC47CA877AC427DHong Wang
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAUEAC47CA877AC427DHong Wang
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAUF021FDA98F6E4D97Rusha Yin
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAUF021FDA98F6E4D97Rusha Yin
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:creator ripekg:author/RIPEAUFD3A39C9334E2ED7Yiwei Zhang
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:creator ripekg:author/RIPEAUFD3A39C9334E2ED7Yiwei Zhang
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:title Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:title Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial dcterms:title Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj dcterms:title Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1002%2F14651858.cd014592.pub2Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1002%2F14651858.cd014592.pub2Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-016-2991-yFemale pelvic organ prolapse using pessaries: systematic review
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-016-2991-yFemale pelvic organ prolapse using pessaries: systematic review
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-016-3000-1Effect of vaginal estrogen on pessary use
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-016-3000-1Effect of vaginal estrogen on pessary use
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-018-3847-4Validation of the Chinese version of the Pelvic Floor Distress Inventory-20 (PFDI-20) according to the COSMIN checklist
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-018-3847-4Validation of the Chinese version of the Pelvic Floor Distress Inventory-20 (PFDI-20) according to the COSMIN checklist
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-020-04654-1ESTROgen use for complications in women treating pelvic organ prolapse with vaginal PESSaries (ESTRO-PESS)-a randomized clinical trial
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-020-04654-1ESTROgen use for complications in women treating pelvic organ prolapse with vaginal PESSaries (ESTRO-PESS)-a randomized clinical trial
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-021-04821-yEffect of vaginal estrogen in postmenopausal women using vaginal pessary for pelvic organ prolapse treatment: a randomized controlled trial
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-021-04821-yEffect of vaginal estrogen in postmenopausal women using vaginal pessary for pelvic organ prolapse treatment: a randomized controlled trial
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-022-05133-5Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00192-022-05133-5Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00404-020-05526-1A prospective study of pessary use for severe pelvic organ prolapse: 3-year follow-up outcomes
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs00404-020-05526-1A prospective study of pessary use for severe pelvic organ prolapse: 3-year follow-up outcomes
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.ijgo.2011.08.021Validation of the Chinese version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire short form (PISQ-12)
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.ijgo.2011.08.021Validation of the Chinese version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire short form (PISQ-12)
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.maturitas.2018.09.003Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.maturitas.2018.09.003Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1080%2F13697137.2018.1520824et alAn epidemiologic study of pelvic organ prolapse in postmenopausal women: a population-based sample in China
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1080%2F13697137.2018.1520824et alAn epidemiologic study of pelvic organ prolapse in postmenopausal women: a population-based sample in China
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1097%2Faog.0000000000003519Pelvic organ prolapse: ACOG Practice Bulletin, Number 214
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1097%2Faog.0000000000003519Pelvic organ prolapse: ACOG Practice Bulletin, Number 214
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1097%2Faog.0b013e3181c2ce96Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1097%2Faog.0b013e3181c2ce96Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1097%2Fgme.0000000000001277Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1097%2Fgme.0000000000001277Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1097%2Fgme.0b013e31820fbcbeChinese validation of the Pelvic Floor Impact Questionnaire Short Form
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1097%2Fgme.0b013e31820fbcbeChinese validation of the Pelvic Floor Impact Questionnaire Short Form
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1097%2Fspv.00000000000012938 Vaginal pessary use and management for pelvic organ prolapse: Developed by the joint writing group of the American Urogynecologic Society and the Society of Urologic Nurses and Associates. Individual writing group members are noted in the Acknowledgments section
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1097%2Fspv.00000000000012938 Vaginal pessary use and management for pelvic organ prolapse: Developed by the joint writing group of the American Urogynecologic Society and the Society of Urologic Nurses and Associates. Individual writing group members are noted in the Acknowledgments section
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1111%2F1471-0528.16950Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1111%2F1471-0528.16950Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1136%2Fbmj.i3853Pelvic organ prolapse
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1136%2Fbmj.i3853Pelvic organ prolapse
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1590%2Fs1677-5538.ibju.2018.0581Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.1590%2Fs1677-5538.ibju.2018.0581Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/10.5468%2Fogs.21232Factors associated with unsuccessful pessary fitting and reasons for discontinuation in Korean women with pelvic organ prolapse
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/10.5468%2Fogs.21232Factors associated with unsuccessful pessary fitting and reasons for discontinuation in Korean women with pelvic organ prolapse
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial http://purl.org/spar/cito/cites ripekg:work/RIPEWF8558F8468E10D92Effect of local estrogen cream on vaginal health after pessary use for prolapsed pelvic organ: a randomized controlled trial
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj http://purl.org/spar/cito/cites ripekg:work/RIPEWF8558F8468E10D92Effect of local estrogen cream on vaginal health after pessary use for prolapsed pelvic organ: a randomized controlled trial
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial rdf:type node1
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj rdf:type node1
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial rdf:type rdfs:Resource
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj rdf:type rdfs:Resource
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial rdf:type owl:Thing
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj rdf:type owl:Thing
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial rdf:type prov:Entity
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj rdf:type prov:Entity
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial rdf:type ripe:WorkWork
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj rdf:type ripe:WorkWork
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial owl:sameAs https://semopenalex.org/work/W4411718338
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj owl:sameAs https://semopenalex.org/work/W4411718338